[{"id":"2751da8c-36e6-4d17-a3c5-a7b73bf6d7a9","acronym":"","url":"https://clinicaltrials.gov/study/NCT04881045","created_at":"2021-05-11T11:52:56.882Z","updated_at":"2024-07-02T16:35:11.665Z","phase":"Phase 1","brief_title":"Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.","source_id_and_acronym":"NCT04881045","lead_sponsor":"Pfizer","biomarkers":" PD-L1","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PF-07257876"],"overall_status":"Completed","enrollment":" Enrollment 29","initiation":"Initiation: 08/18/2021","start_date":" 08/18/2021","primary_txt":" Primary completion: 10/24/2023","primary_completion_date":" 10/24/2023","study_txt":" Completion: 10/24/2023","study_completion_date":" 10/24/2023","last_update_posted":"2024-04-03"}]